Dexilant Sales Data
| Rank 68 | Current sales rank, all U.S. Pharmaceuticals. |
Last updated: February 2014 (updated quarterly).
The following data shows Dexilant U.S. retail sales in Q4 2013 compared to previous quarters.
| Date Range | Sales Rank | Sales ($000) | Units (000) | ||
|---|---|---|---|---|---|
| Q4 2013 | 68 ( 4) |
$238,897 | 7.57% | 1,420 | -2.27% |
| Q3 2013 | 72 ( 2) |
$222,095 | 0.15% | 1,453 | -2.22% |
| Q2 2013 | 70 (7) |
$221,770 | 5.60% | 1,486 | -0.60% |
| Q1 2013 | 77 (2) |
$210,005 | -0.08% | 1,495 | 0.13% |
| Q4 2012 | 75 (5) |
$210,175 | 5.01% | 1,493 | 4.55% |
| Q3 2012 | 80 (10) |
$200,149 | 13.25% | 1,428 | 3.33% |
| Q2 2012 | 90 (10) |
$176,733 | 3.24% | 1,382 | 3.06% |
| Q1 2012 | 100 ( ) |
$171,179 | n/a | 1,341 | n/a |
* Units refer to the number of packages sold.
Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.
